Katelyn E. Connelly, Ph.D., joined the Laboratory of Translational Genomics (LTG) in 2019 as a postdoctoral fellow in the laboratory of Laufey Amundadottir, Ph.D., senior investigator. Dr. Connelly earned her Ph.D. in medicinal chemistry and molecular pharmacology from Purdue University, West Lafayette, Indiana, in 2018. Working with Dr. Emily C. Dykhuizen, her doctoral research focused on understanding the binding and oncogenic mechanisms of the epigenetic regulator CBX8. In 2021, Dr. Connelly was awarded the Sallie Rosen Kaplan Fellowship.
Dr. Connelly is investigating the functional roles of germline variants, identified by genome-wide association studies, in pancreatic cancer risk, under the mentorship of Dr. Amundadottir.